Company News
Alvotech Shares Jump 12% After FDA Review
Alvotech shares surged 12% in pre‑market trading after FDA accepted its BLA for AVT16, an interchangeable biosimilar to Entyvio.
FDA acceptance marks a regulatory milestone, enabling potential pharmac
